Disease Risk Factors
Method to estimate disease risk developed
Published in Medical Letter on the CDC and FDA, April 24th, 2005
According to a study from the United States, "Suppose that one wishes to make inference to the risk of a disease by the population quartile-categories of a key continuous predictor variable. When one collects data on a prospective cohort, the standard method is simply to categorize the key predictor variable by the empirical quartiles. One may then include indicator variables for these empirical quartile-categories as predictors, along with other covariates, in a generalized linear model (GLM),...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Diet & Nutrition
Level of evidence needed for qualified health claim outlined - Food Allergy
ELISA-based assays for detection of peanuts in food validated - Pharmaceutical and Drug Development
pH dependence of binding of drugs to plasma proteins in man reviewed - Sexually Transmitted Diseases
Adverse health burden related to sexual behavior in U.S. reported - Vaccine Efficacy
Difficulty in ranking states' immunization coverage outlined - Acute Lymphocytic Leukemia
Clofarabine's interim results in leukemia reported at symposium - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
